Back to results
US 2026/0217664 A1Published application
Crystalline forms of a tyk2 inhibitor
AssigneeSareum Limited
InventorsJohn Charles READER, Jamie Conor MARSHALL, John MYKYTIUK, Julian Scott NORTHEN
Life of this patent
Estimating the term…
Abstract
The invention provides crystalline forms of a compound having the formula (1): along with methods of making the crystalline forms and pharmaceutical formulations comprising the crystalline forms.
Claims21
1-18. (canceled)
A substantially crystalline form (Form A) of the compound of formula (1):
- having an X-ray powder diffraction pattern characterised by the presence of major peaks at the diffraction angles (2θ) 23.1° and/or 12.3° and/or 16.7° and/or 20.7° and/or 13.7° (±0.2°).
Dependencies are inferred from the claim text.